These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2412918)
1. Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor. Tomlinson DR; Townsend J; Fretten P Diabetes; 1985 Oct; 34(10):970-2. PubMed ID: 2412918 [TBL] [Abstract][Full Text] [Related]
2. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'. Willars GB; Calcutt NA; Tomlinson DR Diabetologia; 1987 Apr; 30(4):239-43. PubMed ID: 2439402 [TBL] [Abstract][Full Text] [Related]
3. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats. Tomlinson DR; Sidenius P; Larsen JR Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664 [TBL] [Abstract][Full Text] [Related]
4. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition. Whiteley SJ; Townsend J; Tomlinson DR; Willars GB Diabetes Res; 1986 Nov; 3(9):447-52. PubMed ID: 2435444 [TBL] [Abstract][Full Text] [Related]
5. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats. Mayer JH; Tomlinson DR Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336 [TBL] [Abstract][Full Text] [Related]
6. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'. Robinson JP; Willars GB; Tomlinson DR; Keen P Brain Res; 1987 Nov; 426(2):339-48. PubMed ID: 2446712 [TBL] [Abstract][Full Text] [Related]
7. Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil. Willars GB; Townsend J; Tomlinson DR; Compton AM; Churchill RD Metabolism; 1988 May; 37(5):442-9. PubMed ID: 2452959 [TBL] [Abstract][Full Text] [Related]
8. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat. Dahlin LB; Archer DR; McLean WG Diabetologia; 1987 Jun; 30(6):414-8. PubMed ID: 2445613 [TBL] [Abstract][Full Text] [Related]
9. Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol. Mayer JH; Tomlinson DR; McLean WG J Neurochem; 1984 Nov; 43(5):1265-70. PubMed ID: 6208327 [TBL] [Abstract][Full Text] [Related]
10. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil. Tomlinson DR; Moriarty RJ; Mayer JH Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576 [TBL] [Abstract][Full Text] [Related]
11. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol. Tomlinson DR; Mayer JH Exp Neurol; 1985 Aug; 89(2):420-7. PubMed ID: 2410289 [TBL] [Abstract][Full Text] [Related]
12. The effect of aldose reductase inhibitor Statil (ICI 128436) on the glucose over-utilization in kidney of diabetic rats. Sochor M; Kunjara S; McLean P Biochem Pharmacol; 1988 Sep; 37(17):3349-56. PubMed ID: 2969732 [TBL] [Abstract][Full Text] [Related]
13. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat. Stribling D; Mirrlees DJ; Harrison HE; Earl DC Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474 [TBL] [Abstract][Full Text] [Related]
14. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats. Cameron NE; Cotter MA; Robertson S Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591 [TBL] [Abstract][Full Text] [Related]
15. Studies of sorbinil on axonal transport in streptozotocin-diabetic rats. Willars GB; Tomlinson DR; Robinson JP Metabolism; 1986 Apr; 35(4 Suppl 1):66-70. PubMed ID: 2421136 [TBL] [Abstract][Full Text] [Related]
16. Statil-sensitive polyol formation in nerve of galactose-fed mice. Calcutt NA; Willars GB; Tomlinson DR Metabolism; 1988 May; 37(5):450-3. PubMed ID: 3130544 [TBL] [Abstract][Full Text] [Related]
17. Defects of axonal transport in experimental diabetes that are unrelated to the sorbitol pathway. Tomlinson DR; Willars GB; Calthrop-Owen EF Exp Neurol; 1987 Apr; 96(1):194-202. PubMed ID: 2435570 [TBL] [Abstract][Full Text] [Related]
18. Prevention of defects of axonal transport in experimental diabetes by aldose reductase inhibitors. Tomlinson DR; Willars GB; Robinson JP Drugs; 1986; 32 Suppl 2():15-8. PubMed ID: 2431858 [TBL] [Abstract][Full Text] [Related]
19. Sorbitol metabolism in the retina, optic nerve, and sural nerve of diabetic rats treated with an aldose reductase inhibitor. Naeser P; Brolin SE; Eriksson UJ Metabolism; 1988 Dec; 37(12):1143-5. PubMed ID: 3143049 [TBL] [Abstract][Full Text] [Related]
20. A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats. Yasuda H; Sonobe M; Hisanaga T; Kawabata T; Maeda K; Kikkawa R; Shigeta Y Metabolism; 1992 Jul; 41(7):778-82. PubMed ID: 1320179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]